SCHEMBL4138460

SCHEMBL4138460

Cc1cccc(C)c1NC(=O)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.67
HPGD P15428 1/20 0.67
KMT2A Q03164 3/20 0.61
LMNA P02545 1/20 0.61
KDM4E B2RXH2 1/20 0.59
KCNK3 O14649 3/20 0.58
KCNK9 Q9NPC2 3/20 0.58
HSP90AA1 P07900 1/20 0.58
ATM Q13315 1/20 0.58
S1PR4 O95977 3/20 0.57
NPC1 O15118 1/20 0.56
MAPT P10636 1/20 0.56
RAB9A P51151 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
LCK P06239 2/20 0.53
MEN1 O00255 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27983640 0.88 KDM4E (0.60) POLBHPGDKMT2ALMNAKDM4E
SCHEMBL21590177 0.88 LCK (0.68) POLBHPGDKMT2ALMNAMAPT
SCHEMBL11665956 0.88 KDM4E (0.78) POLBHPGDKMT2ALMNAKDM4E
SCHEMBL9523014 0.86 S1PR4 (0.69) POLBHPGDKMT2AKDM4ES1PR4
SCHEMBL27872677 0.86 ALDH1A1 (0.68) POLBHPGDKMT2ALMNAKDM4E
SCHEMBL15775601 0.85 KDM4E (0.61) POLBHPGDKMT2ALMNAKDM4E
SCHEMBL9522743 0.85 S1PR4 (0.58) POLBHPGDKMT2AKDM4ES1PR4
SCHEMBL27645790 0.85 LCK (0.66) POLBHPGDKMT2ALMNAKCNK3
SCHEMBL2307872 0.83 S1PR4 (0.56) POLBHPGDKMT2ALMNAKDM4E
Ameltolide SCHEMBL635392 0.83 S1PR4 (0.56) POLBHPGDKMT2ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303291-A1 ROR GAMMA (ROR ) MODULATORS Lead Pharma Holding B.V. (NL) 2018-04-11 EP claimed
WO-2016193452-A1 ROR GAMMA (RORγ) MODULATORS LEAD PHARMA CEL MODELS IP B.V. (NL) 2016-12-08 WO claimed
US-20090105211-A1 INHIBITORS OF HEDGEHOG PATHWAY EXELIXIS, INC. (US) 2009-04-23 US claimed
US-20250326709-A1 THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS PURDUE RESEARCH FOUNDATION (US) 2025-10-23 US disclosed
WO-2022133594-A1 METHODS FOR HYDROAMINOALKYLATION OF OLEFINS AND GROUP 4 METAL COMPLEXES USEFUL IN SUCH METHODS THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2022-06-30 WO disclosed
CN-109912599-A Chemical entities, composition and method 英特利凯恩有限责任公司 2019-06-21 CN disclosed
CN-106188059-B Certain chemical entities, composition and method 英特利凯恩有限责任公司 2019-02-01 CN disclosed
CN-104447727-A Substituted aminopyrimidine compound as well as use method and application thereof GUANGDONG HEC PHARMACEUTICAL 2015-03-25 CN disclosed
EP-2527330-A1 Inhibitors of the hedgehog pathway Exelixis, Inc. (US) 2012-11-28 EP disclosed
US-7589223-B2 Polymerization catalysts, preparation of polyolefins, organotransition metal compounds and ligands BASELL POLYOLEFINE GMBH (DE) 2009-09-15 US disclosed
US-7589223-B2 Polymerization catalysts, preparation of polyolefins, organotransition metal compounds and ligands BASELL POLYOLEFINE GMBH (DE) 2009-09-15 US disclosed
US-7589223-B2 Polymerization catalysts, preparation of polyolefins, organotransition metal compounds and ligands BASELL POLYOLEFINE GMBH (DE) 2009-09-15 US disclosed
EP-1664132-B1 POLYMERIZATION CATALYSTS, PREPARATION OF POLYOLEFINS, ORGANOTRANSITION METAL COMPOUNDS AND LIGANDS BASELL POLYOLEFINE GMBH (DE) 2008-05-07 EP disclosed
EP-1664132-B1 POLYMERIZATION CATALYSTS, PREPARATION OF POLYOLEFINS, ORGANOTRANSITION METAL COMPOUNDS AND LIGANDS BASELL POLYOLEFINE GMBH (DE) 2008-05-07 EP disclosed
US-20070004884-A1 Polymerization catalysts, preparation of polyolefins, organotransition metal compounds and ligands LYONDELL CHEMICAL TECHNOLOGY, L.P. 2007-01-04 US disclosed
US-20070004884-A1 Polymerization catalysts, preparation of polyolefins, organotransition metal compounds and ligands LYONDELL CHEMICAL TECHNOLOGY, L.P. 2007-01-04 US disclosed
US-20070004884-A1 Polymerization catalysts, preparation of polyolefins, organotransition metal compounds and ligands LYONDELL CHEMICAL TECHNOLOGY, L.P. 2007-01-04 US disclosed
EP-1664132-A1 POLYMERIZATION CATALYSTS, PREPARATION OF POLYOLEFINS, ORGANOTRANSITION METAL COMPOUNDS AND LIGANDS Basell Polyolefine GmbH (DE) 2006-06-07 EP disclosed
WO-2005030813-A1 POLYMERIZATION CATALYSTS, PREPARATION OF POLYOLEFINS, ORGANOTRANSITION METAL COMPOUNDS AND LIGANDS BASELL POLYOLEFINE GMBH (DE) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105211-A1 INHIBITORS OF HEDGEHOG PATHWAY SHH, GLI1, SMO POLB 4439/4885HPGD 3021/4885KMT2A 1508/4885
US-20250326709-A1 THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS NAAA, OAT, PAM POLB 180/4885HPGD 800/4885KMT2A 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.